Guidance for Design and Endpoints of Clinical Trials in Chronic Hepatitis B—Report From the 2019 EASL‐AASLD HBV Treatment Endpoints Conference
Representatives from academia, industry, regulatory agencies, and patient groups convened in March 2019 with the primary goal of developing agreement on chronic hepatitis B virus (HBV) treatment endpoints to guide clinical trials aiming to 'cure' HBV. Agreement among the conference partici...
Sparad:
| Huvudupphovsmän: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | engelska |
| Publicerad: |
2019
|
| Länkar: | https://doi.org/10.1002/hep.31030 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hep.31030 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|